GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » 3-Year EPS without NRI Growth Rate

Kingworld Medicines Group (HKSE:01110) 3-Year EPS without NRI Growth Rate : 23.80% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group 3-Year EPS without NRI Growth Rate?

Kingworld Medicines Group's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.02.

During the past 12 months, Kingworld Medicines Group's average EPS without NRI Growth Rate was 37.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 23.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Kingworld Medicines Group was 23.80% per year. The lowest was -32.40% per year. And the median was -4.45% per year.


Competitive Comparison of Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate falls into.



Kingworld Medicines Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Kingworld Medicines Group  (HKSE:01110) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Kingworld Medicines Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines